Bio

Leading the US healthcare efforts, Jeremy Taylor brings twenty years of experience working with life sciences companies, managing M&A, financing and licensing processes, and navigated companies through the capital markets. Mr. Taylor spent four years at the Biotechnology Value Fund, L.P, one of the first biotech hedge funds, The deep diligence skills acquired were further enhanced during the six years that Mr. Taylor advised and developed acquisition strategies for biotech and medtech clients at Montgomery & Co. and Montgomery, Marshall Healthcare Partners, LLC. Spending the last four years focused exclusively on the healthcare capital markets at JMP Securities, Jeremy developed strong relationships with investors in the healthcare space. Mr. Taylor has a Bachelor of Arts in Human Biology (1996) from Stanford University and returned to Stanford and received his MBA at the Stanford Graduate School of Business (2001).